![PS04 enables the company to meet the growing demand for pastille-format alkoxylates and ester, per the company.](https://img.gcimagazine.com/files/base/allured/all/image/2023/12/AdobeStock_530061485.656dffe8e17ca.png?auto=format%2Ccompress&q=70&rect=0%2C100%2C3198%2C1794&w=700)
Croda International Plc recently opened a facility, Pastillator 4 (PS04), at its Seraya site in Jurong Island, Singapore.
PS04 enables the company to meet the growing demand for pastille-format alkoxylates and ester, per the company.
The SGD 22 million (US $16.4 million) investment expands the company's production capacity by an additional 4,600 MT of pastille products, advancing the site’s total capacity to 15,000 MT, per the company.
Related: Croda Launches High SPF and UVA Protection Sunscreen Ingredients
Babu Alagappan, Croda managing director, commented: “Since inception, Croda Singapore has consistently invested in the Seraya site to ensure safe operations. Manufacturing quality, sustainable ingredients based on our customers’ needs is our competitive advantage."